Dergiler / Medicine Science / 2022 / Cilt: 11 - Sayı: 2

The role of triglyceride/glucose index in predicting coronary artery disease severity

Sayfa
617–621
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Triglyceride-Glucose index that can simply be calculated from routine blood parameters, could be a predictive parameter for complex coronary lesions that could need advanced interventions; yet further investigations are needed.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Triglyceride-glucose index is a novel marker for metabolic disorders and insulin resistance and is known to be in close association with the presence, prognosis, and severity of coronary artery disease.
📊
Temel Bulgular & Veri:This study was a retrospective observational cohort study. 310 patients diagnosed with coronary artery disease that underwent coronary angiography between April 2019 and March 2020 were randomly selected from the hospital database and evaluated.
💡
Sonuç & Katkı:Triglyceride-Glucose index that can simply be calculated from routine blood parameters, could be a predictive parameter for complex coronary lesions that could need advanced interventions; yet further investigations are needed.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Triglyceride-glucose index is a novel marker for metabolic disorders and insulin resistance and is known to be in close association with the presence, prognosis, and severity of coronary artery disease. However, few reports were evaluated the predictability of the Triglyceride-glucose index for the severity of coronary artery disease and the need for coronary intervention in patients undergoing coronary angiography. We aimed to evaluate this predictability in our study. This study was a retrospective observational cohort study. 310 patients diagnosed with coronary artery disease that underwent coronary angiography between April 2019 and March 2020 were randomly selected from the hospital database and evaluated. Index was calculated as Ln (fasting triglyceride (mg/dl) × fasting glucose (mg/dl) / 2). Patients were divided into two groups according to final treatment as Medical or Intervention. While glucose values differed significantly between the groups that underwent medical treatment and interventional treatment, triglyceride measurements were found quite close to each other. However, the value of the Triglyceride-Glucose index differed significantly between the groups (p=0.001). The index was found as 9.15±0.69 in the patients who underwent interventional treatment, and it was found to be lower as 8.91±0.54 in the medical treatment group. While total cholesterol, LDL, and HDL differed significantly between the groups. Creatinine, glomerular filtration rate; and ejection fraction values differed significantly between the groups. Triglyceride-Glucose index that can simply be calculated from routine blood parameters, could be a predictive parameter for complex coronary lesions that could need advanced interventions; yet further investigations are needed.

🔖

Bu Makaleye Atıf Yap

ÇELİK, E., ÇORA, A. R. (2022). The role of triglyceride/glucose index in predicting coronary artery disease severity. Medicine Science, Cilt: 11 - Sayı: 2, 617–621. https://ajindex.com/articles/579549

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Fox KAA, Carruthers KF, Dunbar DR, et al. Underestimated and underrecognized: the late consequences of acute coronary syndrome (GRACE UK–Belgian Study). Eur Heart J2010;31:2755-64
  2. Odegaard JI., Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science2013;339:172-7
  3. Caccamo G, Bonura F, Vitale G et al. Insulin resistance and acute coronary syndrome. Atherosclerosis2010;211:672-5
  4. Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10:293-302
  5. Laakso M. Is insulin resistance a feature of or a primary risk factor for cardiovascular disease? Curr Diab Rep. 2015;15:1-9
  6. Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol (Lausanne). 2013;4:37
  7. Zhao LP, Zu WT, Wang L et al. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up. Coron Artery Dis. 2015;26:5-10
  8. Armstrong, EJ, McCabe JM. Insulin resistance and in-stent restenosis: could modulating insulin improve outcomes of percutaneous coronary intervention? Coron Artery Dis. 2015;26:1-2
  9. Miselli MA, Passaro A, Tomasi F et al. Plasma triglycerides predict tenyears all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study. Cardiovasc Diabetol. 2014;13:1-8
  10. Di Angelantonio E, Sarwar N, Perry P et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302:1993-2000
  11. Amiri P, Karimi M, Taherian R et al. Factors associated with pre-diabetes in Tehranian men and women: A structural equations modeling. PloS One. 2017;12: e0188898
  12. Schmidt MI, Duncan BB, Bang H et al. Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care. 2005;28:2013-8
  13. Wilson PWF, Meigs JB, Sullivan L et al. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med. 2007;167:1068-74
  14. Miller M, Seidler A, Pearson TA et al. Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. J Am Coll Cardiol. 1998;31:1252-7
  15. Shaye K, Amir T, Shlomo S et al. Fasting glucose levels within the high normal range predict cardiovascular outcome. Am Heart J. 2012;164:111-6
  16. Angoorani P, Heshmat R, Ejdahed HS et al. Validity of triglyceride–glucose